“Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups”

I’ve written so many posts–more than 1500 since 2007–that I often can’t remember if I’ve already written about something or…not. So very frustrating sometimes…

Case in point: this morning I came across what for me sounded like a “new” study, that is, a study I hadn’t read yet. But it dates to 2015. How could I have missed it? I couldn’t remember posting about it, and searching my blog yielded nothing, nada de nada…

So here I am, sitting in front of my computer, puzzled (I mean, the more I look at this study, the more I KNOW that I have read it before…but perhaps…ah yes that might be IT!…perhaps I neglected to post about it, verybadbadbadofme!) but also amused. The joke’s on me! I should probably keep a record of the studies I post about…Sounds like a great idea, but since I haven’t done it thus far, I probably won’t do it in the future, either…

Well, I suppose it’s better to post about a study TWICE than not to post about it at all, so here goes, without too many details, just in case I’ve written about all this before. ?

The full study is available online for free: goo.gl/LuSij2

In a nutshell, what the Université de Nantes researchers did was test curcumin on a “large panel of human myeloma cell lines.” And that is very important, since previous studies had tested just a few of these lines. The researchers discovered that curcumin killed most MM cell lines, including poor prognosis ones. Very exciting…

The most important part, as far as we are concerned, is the researchers’ conclusion that “Altogether, these results support clinical trials including curcumin in association with standard therapy.” Especially since “chemoresistance remains a major challenge in myeloma treatment.”

Indeed,